Prof. Christopher W. Seder: "Cooperation with the STS database: where do we go next?"

被引:0
|
作者
Liu, Xiao-Mei
机构
关键词
D O I
10.21037/jtd.2017.08.169
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
引用
收藏
页码:E861 / E862
页数:2
相关论文
共 50 条
  • [21] Point-of-care screening for atrial fibrillation: Where are we, and where do we go next?
    Ashburner, Jeffrey M.
    Khurshid, Shaan
    Atlas, Steven J.
    Singer, Daniel E.
    Lubitz, Steven A.
    [J]. CARDIOVASCULAR DIGITAL HEALTH JOURNAL, 2021, 2 (06): : 294 - 297
  • [22] Antimicrobial-resistant Acinetobacter: Where do we go next?
    Datta, Amitesh
    Gandham, Nageswari
    Ajagunde, Jyoti
    Pawar, Vishal D.
    [J]. JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2024, 13 (03) : 1143 - 1144
  • [23] Healthcare-Associated Pneumonia: Where Do We Go Next?
    Restrepo, Marcos I.
    Aliberti, Stefano
    [J]. CLINICAL INFECTIOUS DISEASES, 2014, 58 (03) : 340 - 341
  • [24] The prevention and treatment of postpartum haemorrhage: what do we know, and where do we go to next?
    Weeks, A.
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2015, 122 (02) : 202 - 210
  • [25] Where are we now and where do we go next in terms of the scientific basis for regulation on bioavailability and bioequivalence?
    Williams, RL
    Adams, W
    Chen, ML
    Hare, D
    Hussain, A
    Lesko, L
    Patnaik, R
    Shah, V
    [J]. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2000, 25 (01) : 7 - 12
  • [26] Genotype-guided coumarin dosing: where are we now and where do we need to go next?
    Baranova, Ekaterina V.
    Verhoef, Talitha I.
    Asselbergs, Folkert W.
    de Boer, Anthonius
    Maitland-van der Zee, Anke-Hilse
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2015, 11 (04) : 509 - 522
  • [27] Where are we now and where do we go next in terms of the scientific basis for regulation on bioavailability and bioequivalence?
    R. L. Williams
    W. Adams
    M-L. Chen
    D. Hare
    A. Hussain
    L. Lesko
    R. Patnaik
    V. Shah
    [J]. European Journal of Drug Metabolism and Pharmacokinetics, 2000, 25 : 7 - 12
  • [28] Interview with Prof Dave Ulrich and Dr Santrupt Misra on 'The State of HRM - Where are we? Where do we want to go and how do we get there?
    Thite, Mohan
    Iyer, Ramanathan
    [J]. SOUTH ASIAN JOURNAL OF HUMAN RESOURCE MANAGEMENT, 2023, 10 (02): : 273 - 279
  • [29] Innovations in Phase 1 trial design: Where do we go next?
    Collins, JM
    [J]. CLINICAL CANCER RESEARCH, 2000, 6 (10) : 3801 - 3802
  • [30] Epilogue: Research on the control of plant growth - Where do we go next?
    Lambers, H
    [J]. INHERENT VARIATION IN PLANT GROWTH: PHYSIOLOGICAL MECHANISMS AND ECOLOGICAL CONSEQUENCES, 1998, : 567 - 581